EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Therapeutic tailored approach in patients with diabetes, cardiovascular and renal comorbidities: A cardiologist's view

Ermanno Nardi, Maria Prastaro, Ciro Santoro, Luca Gallo, Luisa Simeoli, Sara Fontanarosa, Stefania Paolillo, Paola Gargiulo, Giovanni Esposito, Pasquale Perrone Filardi

Nutrition, Metabolism and Cardiovascular Diseases · 2025

DOI: 10.1016/j.numecd.2025.104033 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2025. Verfasst von Ermanno Nardi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Cardiovascular Diseases, Sodium-Glucose Transporter 2 Inhibitors, Hypoglycemic Agents. Die Arbeit nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

AIMS: The aim of this narrative review is to explore the management of hypoglycemic drugs in patients with type 2 diabetes mellitus (T2DM) and cardiovascular (CV) or renal disease using the most recent strategies. DATA SYNTHESIS: Cardiovascular diseases (CVD) are the principal source of sickness and mortality in patients with T2DM. The importance of CVD risk factors among individuals with diabetes has been the object of recent investigation and several recommendations have been updated thanks to studies focused on CV outcomes. These trials showed CV and renal protection in recently introduced drug classes, like SGLT-2 (sodium-glucose cotransporter-2) inhibitors and GLP-1 RAs (glucagon-like peptide-1 receptor agonists). CONCLUSIONS: Lowering the likelihood of CV accidents becomes a crucial objective in addition to glucose management. A multimodal management is the priority to counteract micro- and macrovascular complications of T2DM and reduce associated morbidity and mortality in addiction to the control of the other CV risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Cardiovascular DiseasesSodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsBlood GlucoseCardiologistsDiabetic NephropathiesIncretinsHumansTreatment OutcomeRisk AssessmentComorbidityHeart Disease Risk FactorsBiomarkersGlucagon-Like Peptide-1 Receptor AgonistsClinical Decision-MakingRisk FactorsGlucagon-Like Peptide-1 Receptor

Stichwörter der Autor:innen

Atherosclerotic cardiovascular diseaseCardiovascular diseaseChronic kidney diseaseDiabetesHeart failure

Substanzen

Sodium-Glucose Transporter 2 InhibitorsHypoglycemic AgentsBlood GlucoseIncretinsBiomarkersGlucagon-Like Peptide-1 Receptor AgonistsGLP1R protein, humanGlucagon-Like Peptide-1 Receptor

Autor:innen und Institutionen

  • Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy.
  • Department of Advanced Biomedical Sciences, University of Naples Federico II, Naples, Italy. Electronic address: ciro.santoro@unina.it.

Zitieren

APA

Nardi, E., Prastaro, M., Santoro, C., Gallo, L., Simeoli, L., Fontanarosa, S., Paolillo, S., Gargiulo, P., Esposito, G., & Filardi, P. P. (2025). Therapeutic tailored approach in patients with diabetes, cardiovascular and renal comorbidities: A cardiologist's view. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2025.104033

Vancouver

Nardi E, Prastaro M, Santoro C, Gallo L, Simeoli L, Fontanarosa S, et al. Therapeutic tailored approach in patients with diabetes, cardiovascular and renal comorbidities: A cardiologist's view. Nutrition, Metabolism and Cardiovascular Diseases. 2025. doi:10.1016/j.numecd.2025.104033

BibTeX
@article{Nardi2025,
  author = {Nardi, Ermanno and Prastaro, Maria and Santoro, Ciro and Gallo, Luca and Simeoli, Luisa and Fontanarosa, Sara and Paolillo, Stefania and Gargiulo, Paola and Esposito, Giovanni and Filardi, Pasquale Perrone},
  title = {Therapeutic tailored approach in patients with diabetes, cardiovascular and renal comorbidities: A cardiologist's view},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2025},
  doi = {10.1016/j.numecd.2025.104033}
}
Kostenlos starten →